Table 2.

Rates of cancer diagnoses among prior living kidney donors and age- and sex-matched non-donor controls

	Living Donors Rate Per 1000 Person-Years	Matched Controls Rate Per 1000 Person-Years	Donor vs Control Rate Ratio (95% CI)
All LKD
Total Non-skin	11.9	16.2	0.74 (0.55–0.99)*
Total Skin	6.1	6.8	0.91 (0.59–1.40)
By Type, Both Sexes
Melanoma	1.6	0.9	1.67 (0.61–4.59)
Colon	0.3	1.4	0.22 (0.05–1.03)
Lung	0.8	0.9	0.83 (0.25–2.73)
Kidney	0.3	0.9	0.33 (0.07–1.65)
Lymphoma	0.6	1.6	0.40 (0.13–1.28)
Hodgkin’s	--	0.6	--
Leukemia	0.3	0.3	1.00 (0.14–7.10)
Myeloma	0.2	0.5	0.33 (0.03–3.20)
Central nervous system	0.6	0.2	4.00 (0.45–35.8)
Endocrine	0.5	0.5	1.00 (0.20–4.95)
Bone	0.3	0.2	2.00 (0.18–22.1)
Mouth	0.2	0.3	0.50 (0.05–5.51)
Hepatobiliary	--	0.5	--
Esophagus	--	0.2	--
Stomach	--	0.2	--
Bladder	--	0.2	--
Other	0.6	0.6	1.00 (0.25–4.00)
Male-specific
Prostate	6.5	1.7	3.80 (1.42–10.2)*
Testes	0.3	2.4	0.14 (0.02–1.16)
Female-specific
Breast	5.2	8.7	0.60 (0.33–1.08)
Ovary	1.2	--	--
Uterus	1.2	1.2	1.00 (0.25–4.00)

CNS, central nervous system

^*P<0.05